本案例依原書 Table 11.1 完整整理。
保留五個 Benefit Area、Description 與 Example/Observation。
Table 11.1 彙整 AI-powered Chatbot 在 Pharmaceutical Industry 的五類主要 Benefit。
| Benefit area | Description | Example/observation |
|---|---|---|
| Improved customer support | Dosage、drug interaction、delivery issue 的即時 context-aware 回答;24/7 support | Damaged delivery:reporting steps、refund/replacement timeline、temperature-sensitive rule |
| Regulatory compliance assistance | 回答與 FDA/WHO regulation 對齊,協助 pharma personnel compliance | 提供 sensitive product handling/traceability protocol guidance |
| Clinical trial info management | 透過 contextual search/intelligent retrieval 查 trial protocol、result、eligibility | Structured trial data 降低 lookup delay、支援 protocol validation |
| Enhanced drug info dissemination | 即時查 composition、contraindication、alternative | Drug Y kidney compatibility:context-specific、guideline-aligned clinical safety response |
| Supply chain and inventory Mgmt | ERP integration 提供 real-time inventory/delivery schedule;支援 restocking/bulk B2B order | Hospital/clinic:volume discount、custom credit option、priority delivery |
每個 Benefit Area 配對 Process、Data Source、Response Type、Qualitative Observation、Quantitative KPI。
Table 11.1 本身是 Qualitative Benefit Table,沒有 Improvement Percentage。
Benefit Table 說明功能面;真正的 Before/After 數值應到 Table 11.3 驗證,不能用 Qualitative Example 取代 KPI。
請依 Table 11.1 將五個 benefit area 對應到可能的 Table 11.3 KPI,但必須區分 qualitative observation 與 quantitative evidence。